Posted on Leave a comment

Dyslipidemia Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies – Amgen, Kowa Company, AstraZeneca and Parexel

Delveinsight Business Research LLP As per DelveInsight, the Dyslipidemia Market is anticipated to evolve immensely in the coming years owing to the increasing prevalence due to the change in lifestyle, rising obesity cases, rise in healthcare spending across the world, and the launch of new therapies in the market. DelveInsight’s “Dyslipidemia Market Insights, Epidemiology, and […]

Posted on Leave a comment

Deep Partial-thickness Thermal Burns Market expected to rise, Smith+Nephew, MediWound, ConvaTec Inc., 3M, Organogenesis Inc., DeRoyal Industries, Inc., AVITA Medical, expected to drive market

Deep Partial-thickness Thermal Burns Market DelveInsight’s “Deep Partial-Thickness Thermal Burns Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Deep Partial-Thickness Thermal Burns, historical and forecasted epidemiology as well as the Deep Partial-Thickness Thermal Burns market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. […]

Posted on Leave a comment

Pioneering the Fight against Non-Small Cell Lung Cancer Pipeline: A Comprehensive Pipeline Review | Companies – BridgeBio Pharma, Daiichi Sankyo, Merck, Abbvie, Pfizer, Eli Lilly and Others

DelveInsight’s, Non-Small-Cell Lung cancer Pipeline Insight 2023” report provides comprehensive insights about 135+ companies and 150+ pipeline drugs in Non-Small-Cell Lung cancer pipeline landscape. It covers the Non-Small Cell Lung Cancer pipeline drug profiles, including Non-Small Cell Lung Cancer clinical trials and nonclinical stage products. It also covers the Non-Small Cell Lung Cancer therapeutics assessment […]

Posted on Leave a comment

Navigating the Evolving Landscape of Metastatic Triple-Negative Breast Cancer Pipeline Therapeutics: An Extensive Pipeline Analysis | Companies – G1 Therapeutics, CytoDyn, Merck, Gilead Sciences

DelveInsight’s, “Metastatic Triple-Negative Breast Cancer Pipeline Insight 2023” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Metastatic Triple-Negative Breast Cancer (mTNBC) pipeline landscape. It covers the Metastatic Triple-Negative Breast Cancer pipeline drug profiles, including Metastatic Triple-Negative Breast Cancer clinical trials and nonclinical stage products. It also covers the Metastatic Triple-Negative Breast […]

Posted on Leave a comment

Unraveling the Latest Breakthroughs in Brain Metastasis from Breast Cancer Research: A Detailed Pipeline Report | Companies – Novartis, AstraZeneca, Bayer, Merck, Bristol-Myers-Squibb, and Others

DelveInsight’s, “Brain Metastasis from Breast Cancer Pipeline Insight 2023” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Brain Metastasis from the Breast Cancer pipeline landscape. It covers the Brain Metastasis from Breast Cancer pipeline drug profiles, including Brain Metastasis from Breast Cancer clinical trials and nonclinical stage products. It also covers […]

Posted on Leave a comment

Metastatic Prostate Cancer Pipeline: A Roadmap to Potential Breakthroughs in Cancer Treatment | Companies – Zenith Epigenetics, WntResearch, Veru Inc., VasGene Therapeutics, ValiRx, and Others

DelveInsight’s, “Metastatic Prostate Cancer Pipeline Insights, 2023” report provides comprehensive insights about 90+ companies and 110+ pipeline drugs in the metastatic prostate cancer pipeline landscape. It covers the Metastatic Prostate Cancer pipeline drug profiles, including Metastatic Prostate Cancer clinical trials and nonclinical stage products. It also covers the Metastatic Prostate Cancer therapeutics assessment by product […]

Posted on Leave a comment

Prostate Cancer Pipeline Insight: A Comprehensive Overview of Changing Therapies| Companies – Pfizer, Myovant Biosciences, Effector Therapeutics, Mediolanum, Merck, ESSA Pharma, Sanofi, and Others

DelveInsight’s, “Prostate Cancer Pipeline Insight 2023” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Prostate Cancer pipeline landscape. It covers the Prostate Cancer pipeline drug profiles, including Prostate Cancer clinical trials and nonclinical stage products. It also covers the Prostate Cancer pipeline therapeutics assessment by product type, stage, route of […]

Posted on Leave a comment

Innovative Metastatic Castration-Resistant Prostate Cancer Pipeline Highlights Breakthrough Treatments on the Horizon | Companies – AstraZeneca, Hinova pharmaceuticals, POINT Biopharma, Exelixis

DelveInsight’s, “Metastatic Castration-Resistant Prostate Cancer Pipeline Insight, 2023,” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Castration-Resistant Prostate Cancer pipeline landscape. It covers the Metastatic Castration-Resistant Prostate Cancer pipeline drug profiles, including Metastatic Castration-Resistant Prostate Cancer clinical trials and nonclinical stage products. It also covers the Metastatic Castration-Resistant Prostate […]

Posted on Leave a comment

Acurx Pharmaceuticals Completes $4.0 Million Equity Offering That Accelerates Mission To Bring A Front-Line C. difficile Treatment To Market ($ACXP)

Acurx Pharmaceuticals (NasdaqCM: ACXP) announced completing a stock purchase agreement with a single institutional investor in May 2023, offering a mix of shares and warrants to provide ACXP with $4.0 million before fees and offering expenses at $3 per share. Ironically, shares traded lower on the deal’s announcement. But that’s not necessarily bad news. The […]

Posted on Leave a comment

Deep Vein Thrombosis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Bayer, Pfizer, Biocad, MinaPharm Pharmaceuticals, LEO Pharma, Agen

DelveInsight’s “Deep Vein Thrombosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Deep Vein Thrombosis. DelveInsight’s “Deep Vein Thrombosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Deep Vein Thrombosis, historical and forecasted epidemiology as well as the Deep Vein Thrombosis market trends in the […]